---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-000995"
form_type: "8-K"
ticker: "CLRO"
cik: "0000840715"
company_name: "CLEARONE INC"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T10:26:03.547675+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ClearOne receives Nasdaq bid-price deficiency notice; 180-day cure period started Aug 1

## Summary
- Nasdaq letter on Aug 1, 2023: CLRO common stock bid below $1.00 for 30 consecutive trading days.
- Must regain compliance by Jan 29, 2024 by closing at or above $1.00 for 10 consecutive days.
- If not cured, may qualify for additional 180-day period if all other listing standards are met.
- Company may effect a reverse stock split to cure the deficiency; no assurance of compliance.

## SEC filing metadata
- accession: 0001753926-23-000995
- form_type: 8-K
- ticker: CLRO
- cik: 0000840715
- company_name: CLEARONE INC
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/840715/000175392623000995/0001753926-23-000995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/840715/000175392623000995/clro-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-000995
- JSON: https://secwatch.observer/filing/0001753926-23-000995.json
- Plain text: https://secwatch.observer/filing/0001753926-23-000995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.